Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Research
[키워드] 95% confidence interval
acute respiratory syndrome
Adults
Affect
Asymptomatic
asymptomatic infection
average
caused
clinical care
Clinical outcome
coronavirus
correlation
Course
develop
diagnose
dose
Efficacy
Evidence
Future
identify
immune factor
Immunity
implication
infected individual
Infection
inoculated
intranasally
Lateral flow test
median
Neutralizing antibodies
non-randomized
Open-label
participant
Participants
Pathogenesis
peaking
per-protocol analysis
Primary infection
public health
Quantitative
quarantine
rapid antigen test
recommendation
remained
reported
Result
rising
Safety
safety analysis
SARS-CoV-2
SARS-CoV-2 transmission
Serious Adverse Events
Seroconversion
serum
significantly higher
spike-specific IgG
Symptom
Symptoms
TCID50
Tolerability
vaccination
Variation
Viable
viral kinetics
Viral load
virus
Volunteer
were excluded
wild-type virus
[DOI] 10.1038/s41591-022-01780-9 [Article Type] Research
[DOI] 10.1038/s41591-022-01780-9 [Article Type] Research